Patterns of 21-gene Assay Testing and Chemotherapy Use in Black and White Breast Cancer Patients

PURPOSE: In women with early stage, estrogen-receptor (HR)-positive breast cancer, the 21-gene recurrence score (RS) assay quantifies recurrence risk and predicts chemotherapy responsiveness. Recent data suggest that not all women with early-stage, HR+ disease receive this testing. We examined socio...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Clin Breast Cancer
Autori principali: Sheppard, Vanessa B., O’Neill, Suzanne C., Dilawari, Asma, Horton, Sara, Hirpa, Fikru A., Isaacs, Claudine
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2014
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5266534/
https://ncbi.nlm.nih.gov/pubmed/25555816
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clbc.2014.11.011
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi